1Q05 Results Were Strong Overall and Better than Expected; Some Flags in Sigma
|
|
- Leonard Warren
- 5 years ago
- Views:
Transcription
1 Latin American Equity Research Mexico, April 21, Earnings Comment Mexico Conglomerates ALFA (US$4.71) (ALFAA) STRONG BUY TARGET PRICE: US$6.15 1Q05 Results Were Strong Overall and Better than Expected; Some Flags in Sigma Luis Miranda, CFA (5255) News/Analysis: Alfa reported 1Q05 results on April 20 after the market closed. Overall, results were strong and better than expected. On the positive side, we highlight the very strong numbers for Alpek and Nemak, with the latter benefiting from the consolidation of Rautenbach. On the negative side, Sigma s operating margin was affected by higher raw material costs, a structural change in the sales mix, and non-recurring expenses related to the acquisition of New Zealand Milk de Mexico. Alfa s revenue of M$16.7 billion in 1Q05 was 24% higher YoY in real peso terms, 4% higher than our estimate, and 9% higher than consensus. EBITDA of M$2.2 billion was 27% higher YoY, 12% higher than our estimate, and 14% higher than consensus. The operating margin of 9.7% was 80 bps higher than our estimate, mainly because of very strong numbers at Alpek. By division, Alpek (petrochemicals, 53% of sales) reported sales and EBITDA growth of 24% and 35% in real terms, respectively, versus 1Q04. This was driven by a 29% increase in prices, partially offset by a 4% decline in volume that was largely due to maintenance at the polypropylene plant. Nemak (autoparts, 21% of sales) posted top-line growth of 19% versus 1Q04 in real terms, most of which stemmed from the consolidation of the recently acquired European company Rautenbach, which was consolidated for all of 1Q05. EBITDA rose 3% YoY, mainly due to the ramping up of some projects. Sigma (food, 24% of revenues) recorded revenue growth of 27% in 1Q05 versus 1Q04, spurred by volume growth of 23% and a 5% price increase. Nevertheless, the operating margin was 8.4%, 330 bps lower YoY and 240 bps lower than expected, because of the aforementioned factors. Management did not disclose the magnitude of the non-recurring charges. However, we believe that the weak operating margin raises a red flag in regard to Sigma; therefore, we believe the operating performance of this division is a key variable to follow closely. Consolidated net income was 34% higher than expected, mainly due to higher operating results. Consolidated net debt of M$1.23 billion was up 12% YoY, on the back of acquisitions and investments in working capital. Net/Net: This was a strong first quarter for Alfa, in our opinion, and we believe the report could have a positive effect on the stock price. Despite the new concerns about Sigma, overall results were better than our estimates and consensus. We believe that Alpek will continue to post strong numbers in the medium term and that the company s top line should benefit from organic growth and acquisitions at Sigma and Nemak. The main challenge, in our view, will be an improvement in Sigma s profitability and evidence of synergies. Valuation and Risks to Investment Thesis: Our target price is based on a FV/EBITDA multiple of 6.1 times, in line with the company s average in the period (prior to its period of high leverage and weak results), and it is also adjusted for the expected spin-off. The main risks to our investment thesis include: (1) higher-than-expected margin pressure on Alpek and Sigma due to higher cost of raw materials; (2) high exposure to U.S. OEMs; and (3) lower-than-expected economic growth in the U.S. and Mexico. Alfa First-Quarter 2005 Results U.S. Dollars in Millions a Mexican Pesos as of March 2005 in Millions a Sales Op Prof Op Marg EBITDA Net Inc EPS Sales Op Prof Op Marg EBITDA Net Inc EPS 1Q05 1, % ,708 1, % 2,235 1, SI Est 1, % ,009 1, % 1,990 1, Cons 1, % ,326 1, % 1, Q04 1, % ,456 1, % 1,948 1, % Ch Q/Q 3.6% 20.4% % -26.4% -26.4% 1.5% 18.0% % -27.9% -27.3% 1Q04 1, % ,516 1, % 1, % Ch Y/Y 27.9% 38.8% % NM NM 23.6% 34.1% % NM NM a Except per share/adr amounts. NM Not meaningful. Sources: Company reports and Santander Investment estimates.
2 Alfa: 1Q05 Results Valuation Summary (U.S. Dollars in Millions a ) Current Price US$4.71 Target Price US$6.15 Bloomberg ALFAA MM 52-Week Range (US$) US$3.09-US$ E P/E Rel to (Index) (x) E P/E Rel to (Sector) (x) 1.66 Market Capitalization (US$ Mn) US$2,736 Float (%) 35% 3-Mth Avg Daily Vol (US$ Million) 8.3 Shares Outst (ADR xx:1) 581 Net Debt/Equity (x) 0.6 Book Value per ADR (US$) Month Share Price Performance Relative to the IPC (In U.S. Dollar Terms) A-04 J-04 A-04 S-04 N-04 J-05 F-05 A-05 EPS EBITDA FV/ CE Div Div (Local) US$ P/E per ADR EBITDA per ADR P/CE per ADR Yield (%) % % 2005E % 2006E % a Except per share amounts. NA Not available. NM Not meaningful. Sources: Company reports, Economatica, Bloomberg, and Santander Investment estimates Alfa Operating Highlights by Division (U. S. Dollars in Millions) ALFA Sales Operating Margin EBITDA Division 1Q04 4Q04 1Q05 1Q04 4Q04 1Q05 1Q04 4Q04 1Q05 Alepk % 7.3% 9.6% Sigma % 11.6% 8.4% Nemak % 8.0% 7.7% Total 1,159 1,431 1, % 8.4% 9.7% Sources: Company reports, Alpek (53% of sales). The petrochemical division posted sales growth of 24% in real peso terms versus 1Q04 and 28% in dollar terms. This was driven by a 29% increase in prices in peso terms versus 1Q04 and 6% versus 4Q04, which was partially offset by a 4% decline in volume versus 1Q04 and 8% decline versus 4Q04. The volume decline is attributable to lower output of polypropylene due to maintenance as well as a weak month of March due to the Easter holiday (this year in March versus April in 2004). The latter is naturally true for all the divisions. Operating margin in 1Q05 of 9.6% was 120 bps higher than expected and 220 bps higher YoY, as prices of feedstock have stabilized and price increases implemented during the quarter have been accepted by consumers. During 1Q05, Alpek posted EBITDA of US$101 million, the highest level since 2Q97 and US$7 million above our estimate. The three business units, raw materials for polyester, nylon fibers, and plastic-chemicals, posted sequential increases in EBITDA of 16%, 54%, and 6%, respectively. We believe the short-term outlook for this division remains attractive. Although volatility in oil-related products is expected to remain, demand seems to be stable and prices of feedstock have stopped increasing, which should allow the division to continue reporting attractive numbers, at least in the short term. The company should also benefit from higher volume in polypropylene after maintenance downtime in 1Q05 and the start of the new EPS (expandable polystyrene) plant, which came on line at the end of the quarter, increasing capacity by 90,000 tons to 180,000 tons. Sigma (24% of sales). The food division posted a very attractive 27% increase in sales in 1Q05 versus 1Q04 in real peso terms. This was clearly driven by the acquisition of Grupo Chen and Sosua (3Q04) and New Zealand (1Q05); the latter was consolidated for one month during the quarter. Volume increased 23% YoY and prices were up 5% in real peso terms, as the company has been able to pass through higher prices for raw materials. Foreign operations now represent 11.7% of revenues and reported 80% growth YoY. However, at the operating level, the division posted a worrisome 8.4% operating margin and a 10% decline in operating profit versus 1Q04 in real terms. This was partially explained by the change in sales mix, as cheese products have lower margins than cold cuts (Chen and New Zealand are cheese producers) and higher costs IPC 2
3 of raw material, especially milk. However, operating profits were also affected by an undisclosed amount of non-recurring charges related to the acquisition of New Zealand and the company s relaunch of its corporate image. This was the only division that reported EBITDA below our estimate (US$43 million versus our US$45 estimate). Challenging operating outlook. The company stated in its press release that it intends to capitalize on its position on the cheese industry (currently we estimate 31% market share in the domestic market). This will be achieved via synergies, focused on the rationalization of products and distribution, as well as savings in advertising, administrative, and R&D expenses. We will have to closely follow the evolution of this division s performance and the materialization of the expected synergies. Although the weaker-than-expected margins raise some yellow flags that must be monitored, we believe Sigma s management has the capacity and expertise to deliver better numbers in the medium term. Nemak (21% of sales). The division posted strong 19% growth in revenues in real terms in the quarter versus 1Q04, mainly driven by the consolidation for the entire quarter of Rautenbach, the recently acquired European operation. Growth was mainly supported by a 19% increase in volume. Despite the attractive top line growth, EBITDA increased only 3% in real peso terms YoY, as the company had to increase labor expenses on the back of new platforms that the company is developing at its various plants. We believe that during the coming quarter the operating performance of Nemak will improve, as personnel involved with the division s new projects climb up the learning curve. Furthermore, the company will benefit from the consolidation of Rautenbach, which, as we have mentioned before, diversifies the company s client base with higher exposure to European and Asian OEMs. We recognize that these positives are partially offset by the medium-term pressure that the company s high exposure to Ford and GM poses, as the two largest U.S. OEMs continue to suffer strong competition, especially from Asian OEMs. Capex during the quarter was US$152 million, including acquisition. The main projects were the acquisitions of Sigma and Nemak, the ongoing investment in the new polypropylene line, which should be operational by the end of 2006, and the final phase of the EPS plant, which started production in late 1Q05. Net debt increased US$134 million to US$1.2 billion. Nevertheless, we do not believe this is an issue, as interest coverage stands at 8.4 times and net debt to EBITDA is 1.6 times. Bottom Line. We believe 1Q05 results are positive and reinforce our positive view on the stock. We recognize that the outstanding results in Nemak are partially offset by the margin pressure in Sigma. Nevertheless, we believe Sigma s management has the capability to improve profitability. We believe that Alfa will continue reporting solid figures, at least for the next couple of quarters. 3
4 Alfa: 1Q05 Results IMPORTANT DISCLOSURES Alfa Three-Year Stock Performance (U.S. Dollars) M-02 J-02 S-02 D-02 M-03 J-03 S-03 D-03 M-04 J-04 S-04 D-04 M-05 Source: Santander Investment. Dropped Coverage 1/3/03 Alfa (L Axis) B $3.70 1/13/04* B $4.05 1/20/04 B $4.20 3/31/04 IPC (R Axis) SB $6.15 3/10/05 SB $4.30 9/24/04 1,300 1,200 1,100 1, Analyst Recommendations and Price Objectives SB: Strong Buy B: Buy H: Hold UP: Underperform S: Sell UR: Under Review 4
5 IMPORTANT DISCLOSURES (CONTINUED) Key to Investment Codes Rating Definition % of Companies Covered with This Rating % of Companies Provided Investment Banking Services in the Past 12 Months Strong Buy Expected to outperform the local market more than 15%. Buy Expected to outperform the local market 5%-15% % 64.29% Hold Expected to perform within a range of 5% above or below the local market % 21.43% Underperform Expected to underperform the local market 5%-15%. Sell Expected to underperform the local market more than 15% % -- Under Review 10.43% 14.29% The numbers above reflect our Latin American universe. For a discussion, if applicable, of the valuation methods used to determine the price targets included in this report and the risks to achieving these targets, please refer to the latest published research on these stocks. Research is available through your sales representative and other electronic systems. Target prices are 2005 year-end unless otherwise specified. Recommendations are based on a total return basis (expected share price appreciation + prospective dividend yield) unless otherwise specified. Stock price charts and rating histories for companies discussed in this report are also available by written request to Santander Investment Securities Inc., 45 East 53 rd Street, 17 th Floor (Attn: Research Disclosures), New York, NY USA. Ratings are established when the firm sets a target price and/or when maintaining or reiterating the rating. Ratings may not coincide with the above methodology due to price volatility. Management reserves the right to maintain or to modify ratings on any specific stock and will disclose this in the report when it occurs. Valuation methodologies vary from stock to stock, analyst to analyst, and country to country. Any investment in Latin American equities is, by its nature, risky. A full discussion of valuation methodology and risks related to achieving the target price of the subject security is included in the body of this report. The benchmark used for establishing Argentina recommendations is our forecast of the year-end Argentina IFCI index. For the Andean countries, our benchmark is the simple average of the country risk of each country plus the 10 year U.S. T-Bond yield plus 5.5% of equity risk premium. For additional information about our rating methodology, please call (212) This report has been prepared by Santander Investment Securities Inc. ( SIS ) (a subsidiary of Santander Investment S.A., which is wholly owned by Banco Santander Central Hispano, S.A. ("Santander"), on behalf of itself and its affiliates (collectively, Grupo Santander) and is provided for information purposes only. This document must not be considered as an offer to sell or a solicitation of an offer to buy any relevant securities (i.e., securities mentioned herein or of the same issuer and/or options, warrants, or rights with respect to or interests in any such securities). Any decision by the recipient to buy or to sell should be based on publicly available information on the related security and, where appropriate, should take into account the content of the related prospectus filed with and available from the entity governing the related market and the company issuing the security. This report is issued in Spain by Santander Central Hispano Bolsa, Sociedad de Valores, S.A. (SCH Bolsa), and in the United Kingdom by Santander Central Hispano S.A., London Branch (Santander London), which is regulated by the Financial Services Authority in the conduct of investment business in the UK. This report is not being issued to private customers. SCHI, Santander London, and SCH Bolsa are members of Grupo Santander. The following analysts hereby certify that their views about the companies and their securities discussed in this report are accurately expressed and that they have not received and will not receive direct or indirect compensation in exchange for expressing specific recommendations or views in this report: Luis MIranda Grupo Santander receives non-investment banking revenue from the subject company. The information contained herein has been compiled from sources believed to be reliable, but, although all reasonable care has been taken to ensure that the information contained herein is not untrue or misleading, we make no representation that it is accurate or complete and it should not be relied upon as such. All opinions and estimates included herein constitute our judgment as at the date of this report and are subject to change without notice. Any U.S. recipient of this report (other than a registered broker-dealer or a bank acting in a broker-dealer capacity) that would like to effect any transaction in any security discussed herein should contact and place orders in the United States with SIS, which, without in any way limiting the foregoing, accepts responsibility (solely for purposes of and within the meaning of Rule 15a-6 under the U.S. Securities Exchange Act of 1934) for this report and its dissemination in the United States by Santander Investment Securities Inc. All Rights Reserved. 2005
Latin American Equity Research. Alfa Agrees to Sell Hylsamex and Sidor Stakes to Techint
Latin American Equity Research Mexico, May 19, 2005 ALFA Flashnote Mexico Conglomerates STRONG BUY Alfa Agrees to Sell Hylsamex and Sidor Stakes to Techint Luis Miranda, CFA (5255) 5269-1926 lmiranda@santander.com.mx
More informationCEMEX Cemex Increases its Offer for Rinker by 22%
Latin American Equity Research Mexico City, April 10, 2007 Flashnote Mexico Cement & Construction CEMEX Cemex Increases its Offer for Rinker by 22% Gonzalo Fernandez* BUY Vivian Salomón* Mexico: Banco
More informationLatin American Equity Research. Mr. F. Chico to Tender for 42.65% of Asur Shares at M$56.00
Latin American Equity Research Mexico City, March 30, 2007 Flashnote Mexico Airports ASUR Mr. F. Chico to Tender for 42.65% of Asur Shares at M$56.00 BUY Gonzalo Fernández* Vivian Salomón* Mexico: Banco
More informationMEXICAN AIRPORTS EARNINGS PREVIEW
Latin American Equity Research Mexico City, April 20, 2009 Sector Preview Mexico Aerospace & Transportation MEXICAN AIRPORTS EARNINGS PREVIEW A Tough 1Q09, Driven by Weak Passenger Figures Luis Miranda,
More informationCEMEX (US$24.03) Positive 3Q03 Operating Results and Advances on the Financial Front TARGET PRICE: US$27.00
Latin America Quarterly Earnings Report CEMEX (US$24.03) (CX) Mexico Cement & Construction Mexico City, October 9, 2003 U.S. investors inquiries should be directed to Santander Central Hispano Investment
More informationKIMBERLY CLARK DE MEXICO Re-Rating Completed; Downgrading to Hold
Latin American Equity Research Mexico City, November 20, 2006 KIMBERLY CLARK DE MEXICO Re-Rating Completed; Downgrading to Hold Joaquín Ley* Mexico: Santander Banco Santander S.A. 5255) 5269-1921 jley@santander.com.mx
More informationInfonavit Announces its Financial Plan
Latin American Equity Research Mexico City, November 28, 2007 Sector Report Mexico Cement & Construction HOUSING REVIEW NOVEMBER 2007 Infonavit Announces its 2008-2012 Financial Plan Gonzalo Fernández*
More informationWALMEX HOLD. Have You Looked at P/BV? (12/14/05) CURRENT PRICE: US$5.81/M$62.35 TARGET PRICE: US$5.70/M$65.00
Latin American Equity Research Mexico City, December 15, 2005 WALMEX Have You Looked at P/BV? Company Report Mexico Retail HOLD Joaquin Ley* Daniela M. Bretthauer* Mexico: Banco Santander Serfin, S.A Brazil:
More informationICA BUY. ICA Reloaded: Setting 2004 Target, Upgrading to Buy (12/23/03) CURRENT PRICE: US$1.41/M$2.58 TARGET PRICE: US$1.75/M$3.30
Latin American Equity Research ICA Mexico Cement & Construction Mexico City, December 26, 2003 ICA Reloaded: Setting 2004 Target, Upgrading to Buy Gonzalo Fernández (5255) 5269-1931 gofernandez@santander.com.mx
More informationMEXICO TMT SECTOR JANUARY 2011
Latin American Equity Research Mexico City, January 31, 2011 Sector Preview Mexico Telecom, Media & Technology MEXICO TMT SECTOR JANUARY 2011 Post-Cancun Update and 4Q10 Previews Gregorio Tomassi*, CFA
More informationGRUPO AEROPORTUARIO DEL PACIFICO HOLD. Reaches Cruising Altitude; Downgrading to Hold
Latin American Equity Research Mexico City, December 1, 2006 Company Report Mexico Airports GRUPO AEROPORTUARIO DEL PACIFICO Reaches Cruising Altitude; Downgrading to Hold Gonzalo Fernandez* HOLD Vivian
More informationGrowth Opportunities Remain Intact, Introducing YE2011 Target Price
Latin American Equity Research Mexico City, August 2, 2010 Company Report Mexico Healthcare GENOMMA LAB Growth Opportunities Remain Intact, Introducing YE2011 Target Price Joaquin Ley* BUY Daniel Gewehr*
More information2Q16 Highlights: 12M FWD EV/EBITDA 12M PRICE PERFORMANCE VS. IPC P/E
GISSA Market Outperformer 12M FWD Price Target P$45.0 Price 31.4 12M Price Range 29.5/ 33.09 Shares Outstanding 356 Market Cap (Mill) 11,169 Float 19.5% Net Debt (Mill) 46 EV (Mill) 11,164 Dividend Yield
More informationLatin American Equity Research
Latin American Equity Research New York, July 13, 2009 Sector Report Latam Mining MIND THE GAP Worst Case Has Limited Downside Potential GMEXICO VS. PCU Luis Miranda*, CFA Victoria Santaella Alonso Aramburu
More information(5255) (5255)
Latin American Equity Research Mexico City, February 24, 2009 WALMEX For Those About to Buy, We Salute You Upgrading to Buy Joaquin Ley* Company Update Mexico Retail BUY Roberto Liaño* Mexico: Banco Santander
More informationStill Robust Top-Line Growth to Offset Infrastructural Build-Out. Alexander Robarts Joaquin Ley* Alonso Aramburu
Latin American Equity Research New York, July 11, 2006 Company Report Mexico Food GRUMA Still Robust Top-Line Growth to Offset Infrastructural Build-Out BUY Alexander Robarts Joaquin Ley* Alonso Aramburu
More informationOutlook 2016 June, 2016
Outlook 2016 June, 2016 This presentation contains forward-looking information based on numerous variables and assumptions that are inherently uncertain. They involve judgments with respect to, among other
More informationOUTLOOK 2018 May, 2018
May, 2018 This presentation contains forward-looking information based on numerous variables and assumptions that are inherently uncertain. They involve judgments with respect to, among other things, future
More informationAMX AND TMX OCTOBER 2010
Latin American Equity Research Mexico City, October 26, 2010 Sector Report Mexico Telecom & Media AMX AND TMX OCTOBER 2010 No Bargains; Introducing YE2011 Target Prices; Revising Ratings Gregorio Tomassi*,
More informationRASSINI Automotive Industry
RASSINI Market Outperformer 12M FWD Price Target P$49.0 Price 43.31 12M Price Range 28.8 / 39.4 Shares Outstanding 320 Market Cap (Mill) 13,865 Float 30.0% Net Debt (Mill) 1,867 EV (Mill) 16,345 Dividend
More informationFirst Quarter 2015 (1Q15)
Monterrey, Mexico. April 23, 2015 Alpek, S.A.B. de C.V. (BMV: ALPEK) Selected Financial Information (U.S. $ Millions) Total Volume (ktons) (1) Times: Last 12 months Alpek reports 1Q15 EBITDA of U.S. $137
More informationThird Quarter 2018 (3Q18)
Monterrey, Mexico. October 15, 2018 Alpek, S.A.B. de C.V. (BMV: ALPEK) Selected Financial Information (U.S. $ Millions) Alpek reports 3Q18 EBITDA of U.S. $274 million Total Volume (ktons) 1,174 1,151 1,012
More informationGrupo Sura. Equity Research. 4Q14: FX distorts a continuation of good operating trends
Equity Research Grupo Sura 4Q14: FX distorts a continuation of good operating trends Operating lines beat us (again), but FX losses hit bottom line (as expected) Sura s 4Q14 insurance and asset management
More informationSECOND QUARTER 2017 FINANCIAL REPORT ALFA REPORTS 2Q17 EBITDA OF U.S. $522 MILLION
ALFA, S.A.B. DE C.V. SECOND QUARTER 2017 FINANCIAL REPORT ALFA REPORTS 2Q17 EBITDA OF U.S. $522 MILLION Monterrey, N.L., Mexico, July 26, 2017.- ALFA, S.A.B. de C.V. (ALFA), a leading Mexican industrial
More information1Q18 EARNINGS RELEASE. Earnings Release 1Q18 1 / 15
EARNINGS RELEASE 1Q18 1 / 15 Monterrey, Mexico April 27 th, 2018. Grupo Famsa, S.A.B. de C.V. (BMV: GFAMSA), a leading Mexican commercial conglomerate in the retail, consumer and savings sector, announced
More informationCEMEX Cement. Quarterly Report July 27, CX: Proving the success of its Value-before-Volume strategy.
Quarterly Report CEMEX Market Outperformer 12M FWD Price Target US$10.8 Price 7.1 12M Price Range 3.8/8.6 Shares Outstanding (Mill)* 1,542 Market Cap USD (Mill) 10,976 Float 78.6% Net Debt USD (Mill)**
More informationAlmarai Steady performance
RSI10 ALMARAI AB: Saudi Arabia Rating Target price Current price NEUTRAL SAR55.05 (-4.59% upside) SAR57.66 Key themes & implications Almarai reported a positive top-line in Q1 2016, showing resilience
More information3,951 EBITDA 1,174 1,153 1,260 1,284 1,332 Outst shares (mn) 57 EBIT Free float (%)
European Equity Research ACCIONA Facing a Good 2017E Spain Electricity November 7, 2016 (07:15 CET) BUY CURRENT PRICE: 69.01 TARGET PRICE: 82.40 ANA released 9M16 results on Nov 4 and we have adjusted
More informationFirst Quarter 2017 (1Q17)
Monterrey, Mexico. April 24, 2017 Alpek, S.A.B. de C.V. (BMV: ALPEK) Selected Financial Information (U.S. $ Millions) (1) Times: Last 12 months Alpek reports 1Q17 EBITDA of U.S. $158 million Operating
More informationGFAMSA Retail. Quarterly Report July 29, GFAMSA Market Performer 12M FWD Price Target P$8.6
Quarterly Report GFAMSA Market Performer 12M FWD Price Target P$8.6 Price 7.8 12M Price Range 6.77 / 15.34 Shares Outstanding (Mill) 562 Market Cap (Mill) 4,383 Float 36% Net Debt (Mill) 27,728 EV (Mill)
More informationVitro Reports Second Quarter 2018 Results
Vitro Reports Second Quarter 2018 Results 1.1% Year over Year increase in Sales; EBITDA Impacted by Carlisle s Float temporary shutdown San Pedro Garza García, Nuevo León, Mexico, 27 of July -, 2018 Vitro,
More informationMore Growth Ahead at an Attractive Valuation: Raising Target Price
Latin American Equity Research New York, November 22, 2010 Company Report Mexico Mining GRUPO MEXICO More Growth Ahead at an Attractive Valuation: Raising Target Price Victoria Santaella BUY Sergio Matsumoto
More informationAcquisitions Appear Priced In; Downgrading on Valuation vs. Global Peers (212) (212)
Latin American Equity Research New York, June 9, 2008 COCA-COLA FEMSA Company Update Mexico Beverages UNDERPERFORM Acquisitions Appear Priced In; Downgrading on Valuation vs. Global Peers Alexander Robarts
More informationFLASH NOTE Welspun India 31 Jan 17
Oct-11 Feb-12 Jun-12 Oct-12 Feb-13 Jun-13 Oct-13 Feb-14 Jun-14 Oct-14 Feb-15 Jun-15 Oct-15 Feb-16 Jun-16 Oct-16 Feb-17 FLASH NOTE Welspun India 31 Jan 17 CMP (Rs) 76 TP (Rs) 81 Outperformer Key Figures
More informationTHIRD QUARTER 2017 FINANCIAL REPORT ALFA REPORTS 3Q17 EBITDA OF U.S. $400 MILLION
ALFA, S.A.B. DE C.V. THIRD QUARTER 2017 FINANCIAL REPORT ALFA REPORTS 3Q17 EBITDA OF U.S. $400 MILLION Monterrey, N.L., Mexico, October 16, 2017.- ALFA, S.A.B. de C.V. (ALFA), a leading Mexican industrial
More informationThis research has been prepared by Merrill Lynch as part of its services to its clients, and is intended to be used only by those clients when
This research has been prepared by Merrill Lynch as part of its services to its clients, and is intended to be used only by those clients when provided through other means, and in the context of the overall
More informationCEMEX Cement. Quarterly Report February 9, CEMEX remains on track to regain its investment grade.
Quarterly Report CEMEX Market Outperformer 2017 Price Target US$11.0 Price 8.9 12M Price Range 4.1/9.5 Shares Outstanding (Mill)* 1,545 Market Cap USD (Mill) 13,797 Float 78.6% Net Debt USD (Mill)** 12,516
More informationGENOMMA LAB BUY. A Prescription for Growth; Increasing YE2010 Target Price (9/28/09) CURRENT PRICE: M$17.46/US$1.29 TARGET PRICE: M$30.00/US$2.
Latin American Equity Research Mexico City, October 1, 2009 Company Update Mexico Health Care GENOMMA LAB A Prescription for Growth; Increasing YE2010 Target Price BUY Joaquin Ley* Daniel Gewehr* Roberto
More informationCentrale del Latte d'italia
Centrale del Latte d'italia Sales improvement FY17 results Food & beverages Centrale del Latte d Italia s (CLI) price increases, implemented during H1, continue to drive revenue growth, with total revenue
More informationVITRO Conglomerates. Quarterly Report July 29, VITRO Market Outperformer 12M FWD Price Target P$73.0
Quarterly Report VITRO Market Outperformer 12M FWD Price Target P$73.0 Price 61.1 12M Price Range 36.3/ 66.7 Shares Outstanding (Mill) 483.6 Market Cap (Mill) 1,564 Float 20% Net Debt ( Mill) -424 EV Adj.
More informationALFA, S.A.B. DE C.V. SECOND QUARTER 2018 FINANCIAL REPORT ALFA reports record EBITDA of US $676 million in 2Q18, up 30% year-over-year
ALFA, S.A.B. DE C.V. SECOND QUARTER 2018 FINANCIAL REPORT ALFA reports record EBITDA of US $676 million in 2Q18, up 30% year-over-year Monterrey, N.L., Mexico, July 18, 2018.- ALFA, S.A.B. de C.V. (ALFA),
More informationCVC. Equity Research. Another solid sales showing. Latin America Retailing Company Note 07 April 2015
Equity Research CVC Another solid sales showing Promotional environment drove sales in Q1 Bookings rose 11% y/y to R$1.269bn, supported by 6.4% SSS and the opening of 105 stores (totaling 919 exclusive
More informationBharat Forge. Exports remain subdued, outlook better. Source: Company Data; PL Research
Exports remain subdued, outlook better November 08, 2016 Rohan Korde rohankorde@plindia.com +91 22 66322235 Rating BUY Price Rs850 Target Price Rs957 Implied Upside 12.6% Sensex 27,591 Nifty 8,544 (Prices
More informationPetro Rabigh Shutdown marred Q2 results
PETROR AB: Saudi Arabia US$5.07bn 17.4% US$11.19mn Market cap Free float Avg. daily volume RSI10 Vol th Target price n/a n/a Consensus price 32.18 48.3% over current Current price 21.70 as at 17/8/2011
More informationDarden Restaurants, Inc.
Darden Restaurants, Inc. DRI: Reports Solid Performance; Expectations Were Pretty High Despite Evidence Segment Is Slowing Our View: We reiterate our OW rating following shares coming under pressure because
More informationFourth Quarter 2012 (4Q12)
Monterrey, México. February 12, 2013 Alpek, S.A.B. de C.V. (BMV: ALPEK) Alpek reports 4% volume growth despite soft export markets Selected Financial Information (U.S. $ Millions) Contents Pg. Total Volume
More information3Q18 EARNINGS RELEASE. Earnings Release 3Q18 1 / 16
EARNINGS RELEASE 3Q18 1 / 16 Monterrey, Mexico, October 25 th, 2018. Grupo Famsa, S.A.B. de C.V. (BMV: GFAMSA), a leading Mexican commercial conglomerate in the retail, consumer and savings sector, announced
More informationCEMEX HOLD (2/17/09) CURRENT PRICE: US$7.05/M$10.50 TARGET PRICE: US$8.00/M$11.00
Latin American Equity Research Mexico City, February 17, 2009 CEMEX Company Report Mexico Cement & Construction The Long and Winding Road Lowering Target and Reiterating Hold Gonzalo Fernández* Mexico:
More informationLAIDLAW & COMPANY Est. 1842
LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report Alimera Sciences (ALIM - $1.07) Impressive Ex-US Sales Help ALIM Exceed Topline Expectations. ALIM recently announced
More informationBIMBO Food. Quarterly Report October 27, BIMBO Market Underperformer 2016 Price Target P$41.9
Quarterly Report BIMBO Market Underperformer 2016 Price Target P$41.9 Price 51.51 12M Price Range 45.02 / 59.86 Shares Outstanding (Mill) 4,703.2 Market Cap (Mill) 242,262 Float 24.0% Net Debt (Mill) 72,562
More informationMarisa. Equity Research. Poor retail showing despite easy comps; new CFO unveiled. Latin America Retailing Company Note 07 November 2014
Equity Research Marisa Poor retail showing despite easy comps; new CFO unveiled Disappointing top line growth still impacted by the World Cup Marisa posted an SSS decline of 1.5% (vs. 's -7.5%) as: (i)
More informationMahindra and Mahindra Maintain Outperformer. (Rs mn) Mar 14 Mar 15 YoY (%) Dec 14 QoQ (%) FY14 FY15P YoY (%) FY16E YoY (%) FY17E YoY (%)
Batlivala & Karani RESULT UPDATE Mahindra and Mahindra Maintain Outperformer LARGE CAP Share Data Reuters code Bloomberg code MAHM.BO MM IN Market cap. (US$ mn) 12,243 6M avg. daily turnover (US$ mn) 21.0
More informationAllscripts Healthcare Solutions, Inc.
HEALTHCARE: Healthcare Technology Company Update / Estimates Change Allscripts Healthcare Solutions, Inc. MDRX: Continuing the String of Bookings We reiterate our SW rating on Allscripts (MDRX) due to
More informationLuk Fook (590 HK) Hold Target price: HK$ Downgrade to Hold on more challenging HK & Macau market outlook. Equity Research Consumer Discretionary
Equity Research Consumer Discretionary Luk Fook (590 HK) Hold Target price: HK$24.60 Albert Yip, CFA SFC CE No. ADT599 albertyip@gfgroup.com.hk +852 3719 1010 GF Securities (Hong Kong) Brokerage Limited
More informationSABIC Overall strong performance
SABIC AB: Saudi Arabia US$80.80bn 22.6% US$124.7mn Market cap Free float Avg. daily volume RSI10 Vol th Target price 126.0 24.75% over current Consensus price 125.6 24.4% over current Current price 101.0
More informationLAIDLAW & COMPANY Est. 1842
LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report November 7, 2018 Alimera Sciences (ALIM - $1.09) Quarter Mostly in-line, 2019 could Benefit from Repeat Usage ALIM
More informationChow Tai Fook (1929 HK)
Equity Research Consumer Discretionary Chow Tai Fook (1929 HK) Accumulate Target price: HK$11.60 3QFY15 sales disappoint SSS plunge 21% YoY in HK and Macau The sluggish sales was attributable to protest
More informationChina Renewable Energy Investment Ltd (987_HK)
Wednesday, March 21, 2018 www.evaluateresearch.com Target Price HK$ 0.50 Current Price HK$ 0.23 Upside Potential 117% Market Cap. Shares Outstanding HK$ 525 mn $ 66.90 mn 2,364.7 mn Free Float (FF %) 631.9
More informationQ4 EARNINGS REPORT Welspun India 25 Apr 17
Dec-11 Apr-12 Aug-12 Dec-12 Apr-13 Aug-13 Dec-13 Apr-14 Aug-14 Dec-14 Apr-15 Aug-15 Dec-15 Apr-16 Aug-16 Dec-16 Q4 EARNINGS REPORT Welspun India 25 Apr 17 CMP (Rs) 94 TP (Rs) 112 Maintain Outperformer
More informationAIRPORT REVIEW JANUARY 2009 Turbulence Remains Keep Your Seatbelts Fastened
Latin American Equity Research Assumption of Coverage Mexico City, January 6, 2009 Mexico Aerospace & Transportation AIRPORT REVIEW JANUARY 2009 Turbulence Remains Keep Your Seatbelts Fastened Luis Miranda*,
More informationYansab Better than expected results
YANSAB AB: Saudi Arabia US$6.91bn 39.8% US$23.37mn Market cap Free float Avg. daily volume RSI10 Vol th Target price n/a n/a Consensus price 56.00 21.5% over current Current price 46.10 as at 9/2/2011
More informationTakeaways from Bullish Battery Analyst Day
AUTO & TRUCK MANUFACTURING Sector Weighting Market Weight JOHNSON CONTROLS INC. (JCI $39.52 Outperform) Takeaways from Bullish Battery Analyst Day Upbeat, In-Depth Power Solutions (PS) Analyst Day. Yesterday,
More informationEarnings Release 4Q15
Monterrey, Mexico, May 27, 2016. Grupo Famsa, S.A.B. de C.V. (BMV: GFAMSA), a leading Mexican commercial conglomerate in the retail, consumer credit and savings sectors, announced today its earnings results
More information4Q17 EARNINGS RELEASE. Earnings Release 4Q17 1 / 19
EARNINGS RELEASE 4Q17 1 / 19 Monterrey, Mexico May 4 th, 2018. Grupo Famsa, S.A.B. de C.V. (BMV: GFAMSA), a leading Mexican commercial conglomerate in the retail, consumer and savings sector, announced
More informationLARGE CAP & 1,970 BSE
Batlivala & Karani RESULT UPDATE LARGE CAP Share Data Reuters code DIVI.BO Bloomberg code DIVI IN Market cap. (US$ mn) 4,97 6M avg. daily turnover (US$ mn) 4.7 Issued shares (mn) 133 Target price (Rs)
More informationAnta Sports (2020 HK)
Equity Research Consumer Discretionary Anta Sports (2020 HK) Buy (maintained) Target price: HK$18.50 Strong FY14 results; order book momentum maintained FY14 results above expectation Net profit jumped
More informationBradesco. Equity Research. Buys HSBC Brasil for R$17.6bn, or 1.6x P/BV14. Good strategic fit at a higher-than-expected cost
Buys HSBC Brasil for R$17.6bn, or 1.6x P/BV14. Good strategic fit at a higher-than-expected cost 100% of HSBC's operations in Brazil; small EPS impact but Tier 1 down 280bps Bradesco announced earlier
More informationEldorado. Fixed Income Research BTG Pactual Global Research. Weak Q3 on pulp/fx; despite attractive carry, overhangs remain
Fixed Income Research BTG Pactual Global Research Eldorado Brazil Paper Products FixedIncome 25 October 2016 Weak Q3 on pulp/fx; despite attractive carry, overhangs remain EBITDA down 43% y/y on unfavorable
More informationAnta Sports (2020 HK)
Equity Research Consumer Discretionary Anta Sports (2020 HK) Hold (downgraded) Target price: HK$22.80 Albert Yip, CFA SFC CE No. ADT599 albertyip@gfgroup.com.hk +852 3719 1010 GF Securities (Hong Kong)
More informationFigure 1 SAFCO Q1 results Q Q Q (SAR mn) Operating profit % 375.6% 347. Operating margin 47% 8% 30% 40%
Vol mn RSI10 SAFCO Petrochemicals Industrial SAFCO AB: Saudi Arabia US$7.22bn 40% US$5.60mn Market cap Free float Avg. daily volume Target price 62.00-2.6% over current Current price 63.70 as at 8/5/2018
More informationRajesh Exports (RJEX_IN) Earnings Update Report Consumer Discretionary: Gold Jewelry Manufacturer
Monday, February 4, 2019 www.evaluateresearch.com Target Price Rs. 900.00 Current Price Rs. 598.00 Upside Potential 50% Market Cap. Shares Outstanding Rs. 176,802 mn US$ 2.47 bn 295.3 mn Free Float (FF
More informationMarcopolo. Equity Research. Q1 beat our lowered forecasts; strong exports from Brazil. Brazil Transportation Company Note 04 May 2015
Equity Research Marcopolo Q1 beat our lowered forecasts; strong exports from Brazil Results were weak again, but above our call; EPS fell 37% y/y POMO posted a poor set of Q1 results (albeit better-than-expected),
More informationEnbridge Energy Partners, L.P.
Equity Research Earnings Update April 30, 2007 Stock Rating: Sector Performer Sector Weighting: Market Weight 12-18 mo. Price Target $60.00 EEP-NYSE (4/27/07) $61.19 Key Indices: None 3-5-Yr. EPS Gr. Rate
More informationSmall-Cap Research. Integral Technologies, Inc. (ITKG-OTC) ITKG: Upcoming Revenue Catalysts OUTLOOK SUMMARY DATA ZACKS ESTIMATES
Small-Cap Research November 24, 2015 M. Marin 312-265-9211 scr.zacks.com 10 S. Riverside Plaza, Chicago, IL 60606 Integral Technologies, Inc. (ITKG-OTC) ITKG: Upcoming Revenue Catalysts Current Recommendation
More informationManulife Financial Corp.
I N S T I T U T I O N A L E Q U I T Y R E S E A R C H Robert Sedran, CFA 1 (416) 594-7874 Robert.Sedran@cibc.com Koki Akala, CFA 1 (416) 956-3723 Koki.Akala@cibc.com Maurissa Bell, CPA, CA 1 (416) 594-7283
More informationSaudi Arabian Mining Co (Maaden AB Equity) Continuing steady performance
Vol mn RSI10 Saudi Arabian Mining Co- Mining Industrial MAADEN AB: Saudi Arabia 29 May 2018 US$17.47bn 35% US$6.79mn Market cap Free float Avg. daily volume Target price 47.60-15.5% over current Current
More informationAdvanced Petrochemicals Co Upgrade to OW. Raise TP to SAR61/share
Vol mn RSI10 Petrochemicals Industrial APPC AB: Saudi Arabia US$2.891bn 9% US$2.792mn Market cap Free float Avg. daily volume Target price 61.00 10.7% over current Current price 55.10 as at 5/7/2018 Neutral
More informationSecond Quarter 2017 (2Q17)
Monterrey, Mexico. July 26, 2017 Alpek, S.A.B. de C.V. (BMV: ALPEK) Selected Financial Information (U.S. $ Millions) Alpek reports 2Q17 EBITDA of U.S. $82 million Total Volume (ktons) 1,038 986 981 5 6
More information4Q17 EARNINGS RELEASE. Earnings Release 4Q17 1 / 16
EARNINGS RELEASE 4Q17 1 / 16 Monterrey, Mexico February 26 th, 2018. Grupo Famsa, S.A.B. de C.V. (BMV: GFAMSA), a leading Mexican commercial conglomerate in the retail, consumer and savings sector, announced
More informationCETIP. Equity Research. Strong pricing power; good #s are now good news for BVMF; nice risk/return!
Strong pricing power; good #s are now good news for BVMF; nice risk/return! Custody and monthly utilization revs were the main Q1 highlights Given that CETIP s volumes are disclosed on a monthly basis,
More informationA Key Regional Player in the Making: Initiating Coverage with a Buy Rating
Latin American Equity Research Mexico City, December 4, 2007 MEXICHEM Company Report Mexico Chemicals * Employed by a non-us affiliate of Santander Investment Securities, Inc. and is not registered/qualified
More informationDavivienda. Equity Research. Investment Gains Drove Strong 3Q. Colombia Banks (Exclu. Savings & Loan) Company Note 18 November 2013
Equity Research Davivienda Investment Gains Drove Strong 3Q Net income jumped 92% y/y; ROE of 22.3% in 3Q Davivienda s net income almost doubled y/y in 3Q, beating our estimates by 17%, thanks mainly to
More informationThird Quarter 2017 (3Q17)
Monterrey, Mexico. October 16, 2017 Alpek, S.A.B. de C.V. (BMV: ALPEK) Alpek reports 3Q17 EBITDA of U.S. $3 million, including a U.S. -$113 million provision covering the full amount of M&G accounts receivable
More informationAlpek. Equity Research. We update FY16 numbers; LT story still robust
We update FY16 numbers; LT story still robust Hurricane Matthew and planned downtime reduce 4Q volume guidance Following Alpek s 3Q financials and comments by management on 4Q, including the impact of
More informationKingsoft (3888 HK) Buy (maintained) Target price: HK$20.77
Equity Research Information Technology May 24, 216 Kingsoft (3888 HK) Buy (maintained) Target price: HK$2.77 Full-year earnings forecast trimmed as 1Q16 results miss; maintain Buy but lower target price
More informationUNITEDHEALTH GROUP INC
07-16 09-16 11-16 01-17 03-17 05-17 07-17 HEALTHCARE SERVICES Managed Care Market Overweight UNITEDHEALTH GROUP INC (UNH $187.96 Outperform) Expect Strong Q2 + Focus on Early 2018 Commentary Look for solid
More informationSaudi Basic Industries Corp After an upbeat Q3, expect good performance in Q4; Raise TP to SAR103/sh.
Vol mn RSI10 Petrochemicals Industrial SABIC AB: Saudi Arabia US$78.87bn 21% US$83.39mn Market cap Free float Avg. daily volume Target price 103.00 +2.6% over current Current price 100.40 as at 11/6/2017
More informationREVENUES AND EBITDA INCREASED 5% AND 14% VIS- A- VIS 1Q14
ALFA, S.A.B. de C.V. FIRST QUARTER 2015 FINANCIAL REPORT REVENUES AND EBITDA INCREASED 5% AND 14% VIS- A- VIS 1Q14 Monterrey, N.L., Mexico. April 23, 2015.- ALFA, S.A.B. de C.V. ( ALFA ) announced today
More informationChina Modern Dairy (1117 HK)
Equity Research Consumer staples China Modern Dairy (1117 HK) Underperform (Downgraded) Target price: HK$2.75 ASP outlook worsens on China Mengniu settlement price cut Milk powder inventory destocking
More informationALFA Reports 1Q18 EBITDA of US $629 million, a growth of 19% year-over-year
ALFA, S.A.B. DE C.V. FIRST QUARTER 2018 FINANCIAL REPORT ALFA Reports 1Q18 EBITDA of US $629 million, a growth of 19% year-over-year Monterrey, N.L., Mexico, April 18, 2018.- ALFA, S.A.B. de C.V. (ALFA),
More informationFOURTH QUARTER 2017 FINANCIAL REPORT ALFA REPORTS 4Q17 EBITDA OF US $568 MILLION
ALFA, S.A.B. DE C.V. FOURTH QUARTER 2017 FINANCIAL REPORT ALFA REPORTS 4Q17 EBITDA OF US $568 MILLION Monterrey, N.L., Mexico, February 12, 2018.- ALFA, S.A.B. de C.V. (ALFA), a leading Mexican industrial
More informationGenomma Lab FOURTH QUARTER AND FULL YEAR 2015 RESULTS
Mexico City, Mexico, April 27, 2016 Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB.B) ( Genomma Lab or the Company ), today announced its results for the first quarter ended March 31, 2016. All figures
More informationGFINBUR Banks. Quarterly Report July 28, GFINBUR: Strong operating results hidden by non-cash losses.
Quarterly Report GFINBURSA Market Outperformer 2016e Price Target P$39.0 Price 31.16 12M Price Range 27.82 / 42.48 Shares Outstanding (Mill) 6,667 Market Cap (Mill) 207,745 Float 33.6% Deposits (Mill)
More informationVitro Reports 3Q 17 Results
Vitro Reports 3Q 17 Results San Pedro Garza García, Nuevo León, Mexico, October 16, 2017 Vitro, S.A.B. de C.V. (BMV: VITROA), hereinafter Vitro or the Company, a leading glass producer in North America,
More informationLAIDLAW & COMPANY Est. 1842
LAIDLAW & COMPANY London New York San Francisco Boston EQUITY RESEARCH Company Report Alimera Sciences (ALIM - $1.80) Iluvien sales continue their slow & steady growth ALIM reported 1Q16 roughly in-line
More informationCentrale del Latte d'italia
Centrale del Latte d'italia Integration proceeding to plan Q316 results Food & beverages The domestic market remains challenging and beset by deflation, and Centrale del Latte d Italia s (CLI s) flat nine-month
More informationSelected financial information
FIRST QUARTER 2018 REPORT Sigma is a leading multinational refrigerated food company that produces, markets and distributes quality branded foods, including packaged meats, cheese, yogurt and other refrigerated
More informationManulife Financial Corporation
Title: Manulife Financial Corporation - MFC (T) Cdn$13.32 Price: Cdn$13.32 StockRating: Sector Perform TargetPrice: Cdn$14.00 Headline: Title August 7, 2014 The NBF Daily Bulletin MFC (T) Stock Rating:
More informationGoodbaby (1086 HK) Buy (maintained) Target price: HK$ H16 results miss, but margin expansion continues. Equity Research Consumer Discretionary
Equity Research Consumer Discretionary Goodbaby (1086 HK) Buy (maintained) Target price: HK$4.20 1H16 results miss, but margin expansion continues Maintain Buy Net profit rose 21% YoY to HK$107m in 1H16,
More information2Q12. ALFA reports a 10% EBITDA increase yearon year. ALFA, S.A.B. DE C.V.
2Q12 ALFA, S.A.B. DE C.V. ALFA reports a 10% EBITDA increase yearon year. Monterrey, N.L., Mexico. July 16, 2012. ALFA, S.A.B. de C.V. (ALFA) one of Mexico s leading industrial companies, announced today
More information